United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 1,483,300 | 1,448,800 | 1,627,800 | 1,725,300 | 1,598,800 |
| Cost of Goods | 108,100 | 117,600 | 198,700 | 105,700 | 72,700 |
| Gross Profit | 1,375,200 | 1,331,200 | 1,429,100 | 1,619,600 | 1,526,100 |
| Operating Expenses | 781,700 | 1,519,400 | 624,400 | 805,400 | 465,100 |
| Operating Income | 593,600 | -187,600 | 805,400 | 814,900 | 1,061,700 |
| Interest Expense | 23,500 | 44,200 | 13,900 | 9,000 | 3,900 |
| Other Income | 68,800 | 66,800 | -32,600 | -36,400 | 2,400 |
| Pre-tax Income | 638,900 | -165,000 | 758,900 | 769,500 | 1,060,200 |
| Income Tax | 124,100 | -60,500 | 169,700 | 351,600 | 346,500 |
| Net Income Continuous | 514,800 | -104,500 | 589,200 | 417,900 | 713,700 |
| Net Income | $514,800 | $-104,500 | $589,200 | $417,900 | $713,700 |
| EPS Basic Total Ops | 11.65 | -2.39 | 13.54 | 9.50 | 16.29 |
| EPS Basic Continuous Ops | 11.65 | -2.39 | 13.54 | 9.50 | 16.29 |
| EPS Diluted Total Ops | 11.54 | -2.39 | 13.39 | 9.31 | 15.25 |
| EPS Diluted Continuous Ops | 11.54 | -2.39 | 13.39 | 9.31 | 15.25 |
| EPS Diluted Before Non-Recurring Items | 11.54 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $643,500 | $-141,700 | $841,300 | $845,900 | $1,093,300 |